Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 3Completed 3Active not recruiting 3Terminated 2Recruiting 1Not yet recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Uterine Cervical Dysplasia 2Uveal Melanoma 1Uterine Cervical Neoplasms 1Thyroid Nodule 1Thyroid Diseases 1Stomach Neoplasms 1Papillomavirus Infections 1Pancreatic Neuroendocrine Tumors (pNET) 1Oropharyngeal Neoplasms 1Non-Muscle Invasive Bladder Neoplasms 1Neoplasms 1Muscle-invasive Bladder Cancer 1Mouth Neoplasms 1Melanoma 1Esophageal Squamous Cell Carcinoma 1Endometrial Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Hepatocellular 1Acquired Immunodeficiency Syndrome 1

Interventions

Carboplatin 35Pemetrexed 28Cisplatin 23Drug Therapy 22osimertinib 18aflutinib 11Paclitaxel 11tislelizumab 10pembrolizumab 10Surgical Procedures, Operative 10Docetaxel 10Radiotherapy 8Magnetic Resonance Spectroscopy 8anlotinib 7Specimen Handling 7Bevacizumab 7130-nm albumin-bound paclitaxel 7toripalimab 6cemiplimab 6Immunotherapy 6sintilimab 5ensartinib 5durvalumab 5Radiosurgery 5Platinum Compounds 5Nivolumab 5trametinib 4aumolertinib 4Observation 4Injections 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Carcinoma, Non-Small-Cell Lung × Watchful Waiting × Clear all
NCT07388524 2026-05-13

Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial

National Cancer Institute (NCI)

Phase 3 Not yet recruiting
336 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡